Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

The cost-of-illness due to rheumatic heart disease: national estimates for Fiji.

Heenan RC, Parks T, Bärnighausen T, Kado J, Bloom DE, Steer AC.

Trans R Soc Trop Med Hyg. 2020 Mar 31. pii: trz118. doi: 10.1093/trstmh/trz118. [Epub ahead of print]

PMID:
32232393
2.

The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.

Hardy M, Samuela J, Kama M, Tuicakau M, Romani L, Whitfeld MJ, King CL, Weil GJ, Grobler AC, Robinson LJ, Kaldor JM, Steer AC.

PLoS Negl Trop Dis. 2020 Mar 16;14(3):e0008106. doi: 10.1371/journal.pntd.0008106. eCollection 2020 Mar.

3.

Clinical Description and Outcomes of Australian Children With Invasive Group A Streptococcal Disease.

Thielemans E, Oliver J, McMinn A, Baker C, Britton PN, Clark J, Marshall H, Blyth CC, Francis J, Buttery J, Smeesters PR, Crawford N, Steer AC.

Pediatr Infect Dis J. 2020 Feb 20. doi: 10.1097/INF.0000000000002596. [Epub ahead of print]

PMID:
32091492
4.

The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies.

Engelman D, Yoshizumi J, Hay RJ, Osti M, Micali G, Norton S, Walton S, Boralevi F, Bernigaud C, Bowen AC, Chang AY, Chosidow O, Estrada-Chavez G, Feldmeier H, Ishii N, Lacarrubba F, Mahé A, Maurer T, Mahdi MMA, Murdoch ME, Pariser D, Nair PA, Rehmus W, Romani L, Tilakaratne D, Tuicakau M, Walker SL, Wanat KA, Whitfeld MJ, Yotsu RR, Steer AC, Fuller LC.

Br J Dermatol. 2020 Feb 8. doi: 10.1111/bjd.18943. [Epub ahead of print]

PMID:
32034956
5.

Analysis of Global Collection of Group A Streptococcus Genomes Reveals that the Majority Encode a Trio of M and M-Like Proteins.

Frost HR, Davies MR, Delforge V, Lakhloufi D, Sanderson-Smith M, Srinivasan V, Steer AC, Walker MJ, Beall B, Botteaux A, Smeesters PR.

mSphere. 2020 Jan 8;5(1). pii: e00806-19. doi: 10.1128/mSphere.00806-19.

6.

Invasive group A Streptococcus disease in Australian children: 2016 to 2018 - a descriptive cohort study.

Oliver J, Thielemans E, McMinn A, Baker C, Britton PN, Clark JE, Marshall HS, Blyth CC, Francis J, Buttery J, Steer AC, Crawford NW; PAEDS investigators.

BMC Public Health. 2019 Dec 30;19(1):1750. doi: 10.1186/s12889-019-8085-2.

7.

Longitudinal analysis of group A Streptococcus emm types and emm clusters in a high prevalence setting reveals past infection does not prevent future infection.

Campbell PT, Tong SYC, Geard N, Davies MR, Worthing KA, Lacey JA, Smeesters PR, Batzloff MR, Kado J, Jenney AWJ, McVernon J, Steer AC.

J Infect Dis. 2019 Nov 21. pii: jiz615. doi: 10.1093/infdis/jiz615. [Epub ahead of print]

PMID:
31748786
8.

SToP (See, Treat, Prevent) skin sores and scabies trial: study protocol for a cluster randomised, stepped-wedge trial for skin disease control in remote Western Australia.

Mullane MJ, Barnett TC, Cannon JW, Carapetis JR, Christophers R, Coffin J, Jones MA, Marsh JA, Mc Loughlin F, O'Donnell V, Pavlos R, Smith B, Steer AC, Tong SYC, Walker R, Bowen AC.

BMJ Open. 2019 Sep 24;9(9):e030635. doi: 10.1136/bmjopen-2019-030635.

9.

Prevalence of scabies and impetigo in the Solomon Islands: a school survey.

Osti MH, Sokana O, Phelan S, Marks M, Whitfeld MJ, Gorae C, Kaldor JM, Steer AC, Engelman D.

BMC Infect Dis. 2019 Sep 13;19(1):803. doi: 10.1186/s12879-019-4382-8.

10.

The diagnosis of scabies by non-expert examiners: A study of diagnostic accuracy.

Osti MH, Sokana O, Gorae C, Whitfeld MJ, Steer AC, Engelman D.

PLoS Negl Trop Dis. 2019 Aug 19;13(8):e0007635. doi: 10.1371/journal.pntd.0007635. eCollection 2019 Aug.

11.

The Limitations of the Rheumatogenic Concept for Group A Streptococcus: Systematic Review and Genetic Analysis.

de Crombrugghe G, Baroux N, Botteaux A, Moreland NJ, Williamson DA, Steer AC, Smeesters PR.

Clin Infect Dis. 2020 Mar 17;70(7):1453-1460. doi: 10.1093/cid/ciz425.

PMID:
31334754
12.

Author Correction: Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics.

Davies MR, McIntyre L, Mutreja A, Lacey JA, Lees JA, Towers RJ, Duchêne S, Smeesters PR, Frost HR, Price DJ, Holden MTG, David S, Giffard PM, Worthing KA, Seale AC, Berkley JA, Harris SR, Rivera-Hernandez T, Berking O, Cork AJ, Torres RSLA, Lithgow T, Strugnell RA, Bergmann R, Nitsche-Schmitz P, Chhatwal GS, Bentley SD, Fraser JD, Moreland NJ, Carapetis JR, Steer AC, Parkhill J, Saul A, Williamson DA, Currie BJ, Tong SYC, Dougan G, Walker MJ.

Nat Genet. 2019 Aug;51(8):1295. doi: 10.1038/s41588-019-0482-z.

PMID:
31324894
13.

Mass Drug Administration for Scabies - 2 Years of Follow-up.

Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, Tuicakau M, Koroi A, Andrews RM, Kaldor JM, Steer AC.

N Engl J Med. 2019 Jul 11;381(2):186-187. doi: 10.1056/NEJMc1808439. Epub 2019 Jun 26. No abstract available.

PMID:
31242358
14.

The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study.

Weil GJ, Bogus J, Christian M, Dubray C, Djuardi Y, Fischer PU, Goss CW, Hardy M, Jambulingam P, King CL, Kuttiat VS, Krishnamoorthy K, Laman M, Lemoine JF, O'Brian KK, Robinson LJ, Samuela J, Schechtman KB, Sircar A, Srividya A, Steer AC, Supali T, Subramanian S; DOLF IDA Safety Study Group.

PLoS Med. 2019 Jun 24;16(6):e1002839. doi: 10.1371/journal.pmed.1002839. eCollection 2019 Jun.

15.

Scientific Business Abstracts of the 112th Annual Meeting of the Association of Physicians of Great Britain and Ireland.

Chauhan A, Lalor T, Watson S, Adams D, Farrah TE, Anand A, Kimmitt R, Mills NL, Webb DJ, Dhaun N, Kalla R, Adams A, Vatn S, Bonfliglio F, Nimmo E, Kennedy N, Ventham N, Vatn M, Ricanek P, Halfvarson J, Soderhollm J, Pierik M, Torkvist L, Gomollon F, Gut I, Jahnsen J, Satsangi J, Body R, Almashali M, McDowell G, Taylor P, Lacey A, Rees A, Dayan C, Lazarus J, Nelson S, Okosieme O, Corcoran D, Young R, Ciadella P, McCartney P, Bajrangee A, Hennigan B, Collison D, Carrick D, Shaukat A, Good R, Watkins S, McEntegart M, Watt J, Welsh P, Sattar N, McConnachie A, Oldroyd K, Berry C, Parks T, Auckland K, Mentzer AJ, Kado J, Mirabel MM, Kauwe JK, Robson KJ, Mittal B, Steer AC, Hill AVS, Akbar M, Forrester M, Virlan AT, Gilmour A, Wallace C, Paterson C, Reid D, Siebert S, Porter D, Liversidge J, McInnes I, Goodyear C, Athwal V, Pritchett J, Zaitoun A, Irving W, Guha IN, Hanley NA, Hanley KP, Briggs T, Reynolds J, Rice G, Bondet V, Bruce E, Crow Y, Duffy D, Parker B, Bruce I, Martin K, Pritchett J, Aoibheann Mullan M, Llewellyn J, Athwal V, Zeef L, Farrow S, Streuli C, Henderson N, Friedman S, Hanley N, Hanley KP.

QJM. 2018 Dec 1;111(12):920-924. doi: 10.1093/qjmed/hcy193. No abstract available.

PMID:
31222346
16.

The public health control of scabies: priorities for research and action.

Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O, Enbiale W, Engels D, Hay RJ, Hendrickx D, Hotez PJ, Kaldor JM, Kama M, Mackenzie CD, McCarthy JS, Martin DL, Mengistu B, Maurer T, Negussu N, Romani L, Sokana O, Whitfeld MJ, Fuller LC, Steer AC.

Lancet. 2019 Jul 6;394(10192):81-92. doi: 10.1016/S0140-6736(19)31136-5. Epub 2019 Jun 6. Review.

PMID:
31178154
17.

Atlas of group A streptococcal vaccine candidates compiled using large-scale comparative genomics.

Davies MR, McIntyre L, Mutreja A, Lacey JA, Lees JA, Towers RJ, Duchêne S, Smeesters PR, Frost HR, Price DJ, Holden MTG, David S, Giffard PM, Worthing KA, Seale AC, Berkley JA, Harris SR, Rivera-Hernandez T, Berking O, Cork AJ, Torres RSLA, Lithgow T, Strugnell RA, Bergmann R, Nitsche-Schmitz P, Chhatwal GS, Bentley SD, Fraser JD, Moreland NJ, Carapetis JR, Steer AC, Parkhill J, Saul A, Williamson DA, Currie BJ, Tong SYC, Dougan G, Walker MJ.

Nat Genet. 2019 Jun;51(6):1035-1043. doi: 10.1038/s41588-019-0417-8. Epub 2019 May 27. Erratum in: Nat Genet. 2019 Jul 19;:.

18.

Prevalence of scabies and impetigo three years after mass drug administration with ivermectin and azithromycin.

Marks M, Romani L, Sokana O, Neko L, Harrington R, Nasi T, Wand H, Whitfeld MJ, Engelman D, Solomon AW, Kaldor JM, Steer AC.

Clin Infect Dis. 2019 May 25. pii: ciz444. doi: 10.1093/cid/ciz444. [Epub ahead of print]

19.

Controlled human infection for vaccination against Streptococcus pyogenes (CHIVAS): Establishing a group A Streptococcus pharyngitis human infection study.

Osowicki J, Azzopardi KI, Baker C, Waddington CS, Pandey M, Schuster T, Grobler A, Cheng AC, Pollard AJ, McCarthy JS, Good MF, Walker MJ, Dale JB, Batzloff MR, Carapetis JR, Smeesters PR, Steer AC.

Vaccine. 2019 Jun 6;37(26):3485-3494. doi: 10.1016/j.vaccine.2019.03.059. Epub 2019 May 14.

PMID:
31101422
20.

Efficacy of mass drug administration with ivermectin for control of scabies and impetigo, with coadministration of azithromycin: a single-arm community intervention trial.

Romani L, Marks M, Sokana O, Nasi T, Kamoriki B, Cordell B, Wand H, Whitfeld MJ, Engelman D, Solomon AW, Kaldor JM, Steer AC.

Lancet Infect Dis. 2019 May;19(5):510-518. doi: 10.1016/S1473-3099(18)30790-4. Epub 2019 Apr 4.

21.

Neglecting the neglected: the objective evidence of underfunding in rheumatic heart disease.

Macleod CK, Bright P, Steer AC, Kim J, Mabey D, Parks T.

Trans R Soc Trop Med Hyg. 2019 May 1;113(5):287-290. doi: 10.1093/trstmh/trz014.

22.

Systematic Review of Group A Streptococcal emm Types Associated with Acute Post-Streptococcal Glomerulonephritis.

Worthing KA, Lacey JA, Price DJ, McIntyre L, Steer AC, Tong SYC, Davies MR.

Am J Trop Med Hyg. 2019 May;100(5):1066-1070. doi: 10.4269/ajtmh.18-0827.

PMID:
30915958
23.

A Controlled Human Infection Model of Group A Streptococcus Pharyngitis: Which Strain and Why?

Osowicki J, Azzopardi KI, McIntyre L, Rivera-Hernandez T, Ong CY, Baker C, Gillen CM, Walker MJ, Smeesters PR, Davies MR, Steer AC.

mSphere. 2019 Feb 13;4(1). pii: e00647-18. doi: 10.1128/mSphere.00647-18.

24.

The Path to Group A Streptococcus Vaccines: World Health Organization Research and Development Technology Roadmap and Preferred Product Characteristics.

Vekemans J, Gouvea-Reis F, Kim JH, Excler JL, Smeesters PR, O'Brien KL, Van Beneden CA, Steer AC, Carapetis JR, Kaslow DC.

Clin Infect Dis. 2019 Aug 16;69(5):877-883. doi: 10.1093/cid/ciy1143.

25.

Exploration of a simplified clinical examination for scabies to support public health decision-making.

Marks M, Engelman D, Romani L, Mason D, Sokana O, Kama M, Whitfeld M, Steer AC, Kaldor J.

PLoS Negl Trop Dis. 2018 Dec 27;12(12):e0006996. doi: 10.1371/journal.pntd.0006996. eCollection 2018 Dec.

26.

Treatment, prevention and public health management of impetigo, scabies, crusted scabies and fungal skin infections in endemic populations: a systematic review.

May PJ, Tong SYC, Steer AC, Currie BJ, Andrews RM, Carapetis JR, Bowen AC.

Trop Med Int Health. 2019 Mar;24(3):280-293. doi: 10.1111/tmi.13198. Epub 2019 Jan 28.

27.

Scabies: New Opportunities for Management and Population Control.

Thean LJ, Engelman D, Kaldor J, Steer AC.

Pediatr Infect Dis J. 2019 Feb;38(2):211-213. doi: 10.1097/INF.0000000000002211. Review. No abstract available.

PMID:
30299425
28.

Control Strategies for Scabies.

Engelman D, Steer AC.

Trop Med Infect Dis. 2018 Sep 5;3(3). pii: E98. doi: 10.3390/tropicalmed3030098. Review.

29.

Impact of ivermectin administered for scabies treatment on the prevalence of head lice in Atoifi, Solomon Islands.

Coscione S, Esau T, Kekeubata E, Diau J, Asugeni R, MacLaren D, Steer AC, Kositz C, Marks M.

PLoS Negl Trop Dis. 2018 Sep 25;12(9):e0006825. doi: 10.1371/journal.pntd.0006825. eCollection 2018 Sep.

30.

Feasibility and safety of mass drug coadministration with azithromycin and ivermectin for the control of neglected tropical diseases: a single-arm intervention trial.

Romani L, Marks M, Sokana O, Nasi T, Kamoriki B, Wand H, Whitfeld MJ, Engelman D, Solomon AW, Steer AC, Kaldor JM.

Lancet Glob Health. 2018 Oct;6(10):e1132-e1138. doi: 10.1016/S2214-109X(18)30397-8. Erratum in: Lancet Glob Health. 2019 Feb;7(2):e190.

31.

A biological model of scabies infection dynamics and treatment informs mass drug administration strategies to increase the likelihood of elimination.

Lydeamore MJ, Campbell PT, Regan DG, Tong SYC, Andrews RM, Steer AC, Romani L, Kaldor JM, McVernon J, McCaw JM.

Math Biosci. 2019 Mar;309:163-173. doi: 10.1016/j.mbs.2018.08.007. Epub 2018 Aug 24.

PMID:
30149021
32.

Diagnosis, treatment, and control of scabies: can we do better?

Engelman D, Steer AC.

Lancet Infect Dis. 2018 Aug;18(8):822-823. doi: 10.1016/S1473-3099(18)30372-4. Epub 2018 Jun 28. No abstract available.

PMID:
30068496
33.

Primary prevention of rheumatic fever in the 21st century: evaluation of a national programme.

Jack SJ, Williamson DA, Galloway Y, Pierse N, Zhang J, Oliver J, Milne RJ, Mackereth G, Jackson CM, Steer AC, Carapetis JR, Baker MG.

Int J Epidemiol. 2018 Oct 1;47(5):1585-1593. doi: 10.1093/ije/dyy150.

PMID:
30060070
34.

International survey of paediatric infectious diseases consultants on the management of community-acquired pneumonia complicated by pleural empyema.

Osowicki J, Steer AC.

J Paediatr Child Health. 2019 Jan;55(1):66-73. doi: 10.1111/jpc.14128. Epub 2018 Jul 27.

PMID:
30051535
35.

Randomized Trial of Community Treatment With Azithromycin and Ivermectin Mass Drug Administration for Control of Scabies and Impetigo.

Marks M, Toloka H, Baker C, Kositz C, Asugeni J, Puiahi E, Asugeni R, Azzopardi K, Diau J, Kaldor JM, Romani L, Redman-MacLaren M, MacLaren D, Solomon AW, Mabey DCW, Steer AC.

Clin Infect Dis. 2019 Mar 5;68(6):927-933. doi: 10.1093/cid/ciy574.

36.

Consensus criteria for the diagnosis of scabies: A Delphi study of international experts.

Engelman D, Fuller LC, Steer AC; International Alliance for the Control of Scabies Delphi panel.

PLoS Negl Trop Dis. 2018 May 24;12(5):e0006549. doi: 10.1371/journal.pntd.0006549. eCollection 2018 May.

37.

WHO/IVI global stakeholder consultation on group A Streptococcus vaccine development: Report from a meeting held on 12-13 December 2016.

Osowicki J, Vekemans J, Kaslow DC, Friede MH, Kim JH, Steer AC.

Vaccine. 2018 Jun 7;36(24):3397-3405. doi: 10.1016/j.vaccine.2018.02.068. Epub 2018 Feb 26.

PMID:
29496349
38.

Question 1: Is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg?

Wilkins AL, Steer AC, Cranswick N, Gwee A.

Arch Dis Child. 2018 May;103(5):514-519. doi: 10.1136/archdischild-2017-314505. Epub 2018 Feb 20. Review. No abstract available.

PMID:
29463522
39.

Rheumatic fever: The rebound phenomenon returns.

Osowicki J, Carr JP, Steer AC.

J Paediatr Child Health. 2018 Jun;54(6):685-688. doi: 10.1111/jpc.13848. Epub 2018 Feb 7. No abstract available.

PMID:
29411467
40.

Prospective Surveillance of Pediatric Invasive Group A Streptococcus Infection.

Ching NS, Crawford N, McMinn A, Baker C, Azzopardi K, Brownlee K, Lee D, Gibson M, Smeesters P, Gonis G, Ojaimi S, Buttery J, Steer AC.

J Pediatric Infect Dis Soc. 2019 Mar 28;8(1):46-52. doi: 10.1093/jpids/pix099.

PMID:
29309631
41.

Immune Cross-Opsonization Within emm Clusters Following Group A Streptococcus Skin Infection: Broadening the Scope of Type-Specific Immunity.

Frost HR, Laho D, Sanderson-Smith ML, Licciardi P, Donath S, Curtis N, Kado J, Dale JB, Steer AC, Smeesters PR.

Clin Infect Dis. 2017 Oct 16;65(9):1523-1531. doi: 10.1093/cid/cix599.

PMID:
29020160
42.

Neurodevelopmental outcomes for high-risk neonates in a low-resource setting.

Milner KM, Duke T, Steer AC, Kado JH, Koyamaibole L, Kaarira R, Namudu K, Woolfenden S, Miller AE, O'Heir KE, Neal EFG, Roberts G.

Arch Dis Child. 2017 Nov;102(11):1063-1069. doi: 10.1136/archdischild-2017-312770. Epub 2017 Aug 28.

PMID:
28847882
43.

Global, Regional, and National Burden of Rheumatic Heart Disease, 1990-2015.

Watkins DA, Johnson CO, Colquhoun SM, Karthikeyan G, Beaton A, Bukhman G, Forouzanfar MH, Longenecker CT, Mayosi BM, Mensah GA, Nascimento BR, Ribeiro ALP, Sable CA, Steer AC, Naghavi M, Mokdad AH, Murray CJL, Vos T, Carapetis JR, Roth GA.

N Engl J Med. 2017 Aug 24;377(8):713-722. doi: 10.1056/NEJMoa1603693.

44.

The Epidemiology of Scabies and Impetigo in Relation to Demographic and Residential Characteristics: Baseline Findings from the Skin Health Intervention Fiji Trial.

Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H, Tikoduadua L, Tuicakau M, Koroi A, Ritova R, Andrews R, Kaldor JM, Steer AC.

Am J Trop Med Hyg. 2017 Sep;97(3):845-850. doi: 10.4269/ajtmh.16-0753. Epub 2017 Jul 19.

45.

Secondary prevention for screening detected rheumatic heart disease: opportunities to improve adherence.

Engelman D, Ah Kee M, Mataika RL, Kado JH, Colquhoun SM, Tulloch J, Steer AC.

Trans R Soc Trop Med Hyg. 2017 Apr 1;111(4):154-162. doi: 10.1093/trstmh/trx035.

PMID:
28673022
46.

Toxic shock syndrome - the seven Rs of management and treatment.

Wilkins AL, Steer AC, Smeesters PR, Curtis N.

J Infect. 2017 Jun;74 Suppl 1:S147-S152. doi: 10.1016/S0163-4453(17)30206-2. Review.

PMID:
28646955
47.

Systematic review of the diagnosis of scabies in therapeutic trials.

Thompson MJ, Engelman D, Gholam K, Fuller LC, Steer AC.

Clin Exp Dermatol. 2017 Jul;42(5):481-487. doi: 10.1111/ced.13152. Epub 2017 May 29. Review.

PMID:
28556185
48.

Association between a common immunoglobulin heavy chain allele and rheumatic heart disease risk in Oceania.

Parks T, Mirabel MM, Kado J, Auckland K, Nowak J, Rautanen A, Mentzer AJ, Marijon E, Jouven X, Perman ML, Cua T, Kauwe JK, Allen JB, Taylor H, Robson KJ, Deane CM, Steer AC, Hill AVS; Pacific Islands Rheumatic Heart Disease Genetics Network.

Nat Commun. 2017 May 11;8:14946. doi: 10.1038/ncomms14946.

49.

Clinical outcomes for young people with screening-detected and clinically-diagnosed rheumatic heart disease in Fiji.

Engelman D, Mataika RL, Ah Kee M, Donath S, Parks T, Colquhoun SM, Carapetis JR, Kado JH, Steer AC.

Int J Cardiol. 2017 Aug 1;240:422-427. doi: 10.1016/j.ijcard.2017.04.004. Epub 2017 Apr 6.

50.

Clinical development strategy for a candidate group A streptococcal vaccine.

Schödel F, Moreland NJ, Wittes JT, Mulholland K, Frazer I, Steer AC, Fraser JD, Carapetis J.

Vaccine. 2017 Apr 11;35(16):2007-2014. doi: 10.1016/j.vaccine.2017.02.060. Epub 2017 Mar 16. Review.

PMID:
28318768

Supplemental Content

Loading ...
Support Center